The objective of EAMG is to ensure a favorable climate for use of allergen extracts for specific diagnostics of allergy and specific allergen immunotherapy treatment.

Areas of activities:

• Creation of public and health authority awareness of the benefits that can be gained with specific diagnostic and therapeutic allergen vaccines.
• Establishment and maintenance of the allergen vaccines segment within the pharmaceutical industry.
• Collaboration with the regulatory environment in order to introduce uniform implementation of regulation to allergen products in Europe.
• Support to professionals, academic organizations and regulatory bodies in Europe and globally.
• Stimulating research and continuously improving of allergen products as well as new technologies.
• Ensure high level industrial quality standards.
• Support to educational programs aimed at establishment and maintenance of allergology as a medical specialty.
• Increase of the liaison with national and international pharmaceutical industry associations.
• Developing educational programs for allergic patients aimed at a better understanding of their disease, opportunities for specific diagnosis and treatment.